Induction chemotherapy combined with three-dimensional conformal radiation therapy for locally advanced non small cell lung cancer

( views:, downloads: )
Author:
ZHENG Ai-qing()
YU Jin-ming()
ZHAO Xian-guang()
WANG Xue-tao()
WEI Guang-sheng()
Journal Title:
CHINESE JOURNAL OF RADIATION ONCOLOGY
Issue:
Volume 14, Issue 03, 2005
DOI:
Key Word:

Abstract:

  • [1]Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer, 2001,31:43-56.
  • [2]Martel MK, Ten-Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of nonsmall cell lung cancer patients. Lung Cancer, 1999,24:31-37.
  • [3]于金明.二十一世纪的放射肿瘤学.中华肿瘤杂志,2002,24:521-525.
  • [4]Ragazzi G, Cattaneo GM, Fiorino C. Use of dose-volume histograms and biophysical models to compare 2D and 3D irradiation techniques for nonsmall cell lung cancer. Br J Radiol, 1999,72:279-288.
  • [5]李万龙,于金明,刘国华,等.非小细胞肺癌影像学与病理学靶区关系的研究.中华肿瘤杂志,2003,25:566-568.
  • [6]Ready NE, Vokes EE.Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer. Lung Cancer, 2003,42 Suppl 2: S65-69.
  • [7]Dillman RO,Hemdon J,Seagren SL,et al. Improved survival in stage Ⅲ non-small-cell lung cancer: seven-year follow-up of Cancer and Group B (CALGB)8433 trial. J Natl Cancer Inst, 1996,88:1210-1215.
  • [8]Chen LM, Ignacio L, Jacobs R, et al. Results of a phase Ⅱ concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage Ⅲ non-small-cell lung cancer.Radiat Oncol Investig, 1999,7: 49-53.
  • [9]蔡勇,张珊文,尹先哲,等.放射治疗同时化疗Ⅲ期非小细胞肺癌.中华放射肿瘤学杂志,2001,10:31-33.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn